Carnaghi C - Search Results

1

Fatal infusion reaction to cetuximab: the need for predictive risk factors and safer patient selection.

Tronconi MC, Sclafani F, Rimassa L, Carnaghi C, Personeni N, Santoro A. Tronconi MC, et al. Among authors: carnaghi c. J Clin Oncol. 2011 Aug 10;29(23):e680-1. doi: 10.1200/JCO.2011.35.5651. Epub 2011 Jun 20. J Clin Oncol. 2011. PMID: 21690469 Free article. No abstract available.

2

Preliminary experience with high-dose cisplatin, reduced glutathione and natural interferon-alpha in dacarbazine-resistant malignant melanoma.

Bajetta E, Rimassa L, Carnaghi C, Del Vecchio M, Celio L, Cassata A. Bajetta E, et al. Among authors: carnaghi c. Tumori. 1998 Jan-Feb;84(1):48-51. doi: 10.1177/030089169808400110. Tumori. 1998. PMID: 9619714 Clinical Trial.

3

5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors.

Bajetta E, Rimassa L, Carnaghi C, Seregni E, Ferrari L, Di Bartolomeo M, Regalia E, Cassata A, Procopio G, Mariani L. Bajetta E, et al. Among authors: carnaghi c. Cancer. 1998 Jul 15;83(2):372-8. doi: 10.1002/(sici)1097-0142(19980715)83:2<372::aid-cncr23>3.0.co;2-p. Cancer. 1998. PMID: 9669822 Clinical Trial.

4

Clinical significance of neuroendocrine phenotype in non-small-cell lung cancer.

Carnaghi C, Rimassa L, Garassino I, Santoro A. Carnaghi C, et al. Ann Oncol. 2001;12 Suppl 2:S119-23. doi: 10.1093/annonc/12.suppl_2.s119. Ann Oncol. 2001. PMID: 11762337 Free article. Review.

5

Irinotecan and raltitrexed: an active combination in advanced colorectal cancer.

Carnaghi C, Rimassa L, Garassino I, Zucali PA, Masci G, Fallini M, Morenghi E, Santoro A. Carnaghi C, et al. Ann Oncol. 2002 Sep;13(9):1424-9. doi: 10.1093/annonc/mdf229. Ann Oncol. 2002. PMID: 12196368 Free article. Clinical Trial.

6

Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?

Masci G, Magagnoli M, Zucali PA, Castagna L, Carnaghi C, Sarina B, Pedicini V, Fallini M, Santoro A. Masci G, et al. Among authors: carnaghi c. J Clin Oncol. 2003 Feb 15;21(4):736-9. doi: 10.1200/JCO.2003.02.042. J Clin Oncol. 2003. PMID: 12586814

7

Unexpected low efficacy of stealth liposomal doxorubicin (Caelyx) and vinorelbine in metastatic breast cancer.

Rimassa L, Carnaghi C, Garassino I, Salvini P, Ginanni V, Gullo G, Morenghi E, Santoro A. Rimassa L, et al. Among authors: carnaghi c. Breast Cancer Res Treat. 2003 Jan;77(2):185-8. doi: 10.1023/a:1021300719965. Breast Cancer Res Treat. 2003. PMID: 12602917 Clinical Trial.

8

Minidose warfarin is associated with a high incidence of International Normalized Ratio elevation during chemotherapy with FOLFOX regimen.

Magagnoli M, Masci G, Carnaghi C, Zucali PA, Castagna L, Morenghi E, Santoro A. Magagnoli M, et al. Among authors: carnaghi c. Ann Oncol. 2003 Jun;14(6):959-60. doi: 10.1093/annonc/mdg238. Ann Oncol. 2003. PMID: 12796035 Free article. No abstract available.

9

Metastatic colorectal cancer: integrating irinotecan into combination and sequential chemotherapy.

Douillard JY, Sobrero A, Carnaghi C, Comella P, Díaz-Rubio E, Santoro A, Van Cutsem E. Douillard JY, et al. Among authors: carnaghi c. Ann Oncol. 2003;14 Suppl 2:ii7-12. doi: 10.1093/annonc/mdg723. Ann Oncol. 2003. PMID: 12810451 Free article. Review.

10

Metastasis of hepatocellular carcinoma to the heart: a case report and review of the literature.

Masci G, Magagnoli M, Grimaldi A, Covini G, Carnaghi C, Rimassa L, Santoro A. Masci G, et al. Among authors: carnaghi c. Tumori. 2004 May-Jun;90(3):345-7. doi: 10.1177/030089160409000317. Tumori. 2004. PMID: 15315319 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters